跳至主要内容
临床试验/NCT04636177
NCT04636177已完成不适用

Pain Rehabilitation Virtual Reality (PRVR): Innovations to Enhance Mobility in the Presence of Pain

Stanford University4 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2022年3月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
4
主要终点
VR Duration of Use Per Week

研究概览

简要总结

The proposed research is a single arm feasibility trial of pain rehabilitation virtual reality (PRVR) aimed at measuring feasibility, acceptability and utility of VR as well as changes in physical function and fear for adolescents with chronic musculoskeletal pain. The intervention includes standard physiotherapy treatment including functional goal setting and progressive exercise.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 10 to 17 years old
  • Musculoskeletal pain (e.g. localized [back, limb], diffuse) not due to acute trauma (e.g. active sprain or fracture)
  • English Language Proficiency

排除标准

  • Significant cognitive impairment (e.g., brain injury)
  • Significant medical or psychiatric problem that would interfere (e.g. psychosis, suicidality)
  • Presents with a condition that interferes with virtual reality usage (e.g., history of seizure, facial injury precluding safe placement of headset, visual impairment, significant hearing impairment impact ability to follow audio instructions).

结局指标

主要结局

VR Duration of Use Per Week

时间窗: Baseline to end of treatment across 6-8 weeks, on average

This outcome is to assess Feasibility, Acceptability, and Utility of VR.

Participant Rated Ease of Use

时间窗: End of treatment at 6-8 weeks, on average

This outcome is to assess Feasibility, Acceptability, and Utility of VR.

Participant Rated Enjoyment

时间窗: End of treatment at 6-8 weeks, on average

This outcome is to assess Feasibility, Acceptability, and Utility of VR.

次要结局

  • Pain-related Fear and Avoidance(Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment)
  • Physical Function: Lower Extremity(Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment)
  • Physical Function: Upper Extremity(Baseline to end of treatment at 6-8 weeks, on average and at 3-months after end of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Laura E Simons

Professor

Stanford University

研究点 (4)

Loading locations...

相似试验